A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene

被引:0
作者
Monica Gelzo
Maria Donata Di Taranto
Alvino Bisecco
Alessandra D’Amico
Rocco Capuano
Carola Giacobbe
Mafalda Caputo
Mario Cirillo
Gioacchino Tedeschi
Giuliana Fortunato
Gaetano Corso
机构
[1] Federico II University,Department of Molecular Medicine and Medical Biotechnologies
[2] Naples,Department of Advanced Medical and Surgical Sciences
[3] Italy,Department of Advanced Biomedical Sciences, Neuroradiology Units
[4] CEINGE Advanced Biotechnologies,Department of Clinical and Experimental Medicine
[5] University of Campania “Luigi Vanvitelli”,undefined
[6] Federico II University,undefined
[7] University of Foggia,undefined
来源
Acta Neurologica Belgica | 2021年 / 121卷
关键词
Cerebrotendinous Xanthomatosis; CYP27A1; Sterol 27-hydroxylase; Bile acid biosynthesis disorder; Neurological dysfunction;
D O I
暂无
中图分类号
学科分类号
摘要
Cerebrotendinous Xanthomatosis (CTX) is an autosomal recessive defect of the alternative pathway of bile acid biosynthesis, due to the deficiency of mitochondrial cytochrome P450 sterol 27-hydroxylase enzyme encoded by CYP27A1. The deficit of sterol 27-hydroxylase raises cholestanol in plasma and tissues of affected patients. Although there is a marked variability of signs, symptoms, severity and age of onset, the main clinical manifestations of CTX include chronic diarrhea, bilateral cataract, tendon xanthomas and neurological dysfunction. Herein, we report the clinical, biochemical and molecular characterization of a Caucasian female affected by CTX diagnosed at 28 years. The patient’s clinical history revealed neurological and behavioral manifestations already at fifth year of life, following by bilateral cataract and chronic diarrhea without xanthomas. At diagnosis, an involvement of the cervical spinal cord was also observed on MRI. Sterols profile analysis in plasma and red blood cell membranes showed very high cholestanol levels. CYP27A1 sequencing revealed a new variant (e.g., c.850_854delinsCTC) at homozygous status. The follow-up after 5 months of chenodeoxycholic acid treatment showed a decrease of plasma cholestanol of 64%. After 1 year, the patient showed normalization of bowel function, reduction of risk of falls, improvement of cognitive function although brain and spine MRI and other instrumental examinations remained unchanged. This case highlights the variability of the CTX phenotype that makes it difficult to reach an early diagnosis. Biochemical and/or molecular screening of CTX should be taken into account to early start the pharmacological treatment limiting neurological damages.
引用
收藏
页码:561 / 566
页数:5
相关论文
共 144 条
[1]  
Corso G(2017)Liver and the defects of cholesterol and bile acids biosynthesis: rare disorders many diagnostic pitfalls World J Gastroenterol 23 5257-5265
[2]  
Dello Russo A(2000)Presence of diarrhea and absence of tendon xanthomas in patients with cerebrotendinous xanthomatosis Arch Neurol 57 520-524
[3]  
Gelzo M(2014)A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis J Inherit Metab Dis 37 421-429
[4]  
Verrips A(2014)Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management Orphanet J Rare Dis 27 143-149
[5]  
van Engelen BG(2006)Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene Neurol Sci 49 2039-2046
[6]  
Wevers RA(2011)Sterol profiles in plasma and erythrocyte membranes in patients with Smith-Lemli-Opitz syndrome: a six-year experience Clin Chem Lab Med 907 154-158
[7]  
van Geel BM(2012)A routine method for cholesterol and 7-dehydrocholesterol analysis in dried blood spot by GC-FID to diagnose the Smith-Lemli-Opitz syndrome J Chromatogr B Analyt Technol Biomed Life Sci 31 1185-1188
[8]  
Cruysberg JR(2016)Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports Metab Brain Dis 7 15282-424
[9]  
van den Heuvel LP(2017)Identification and in vitro characterization of two new PCSK9 gain of function variants found in patients with Familial Hypercholesterolemia Sci Rep 17 405-304
[10]  
Keyser A(2015)Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Genet Med 116 298-781